[
  {
    "doc_id": "PMID_41563617",
    "summary": "Reoperations for ERM removal occurred exclusively in the non-ILM peeling group. Reoperations for ERM removal occurred exclusively in the non-ILM peeling group. No significant intergroup differences were found in CMT, foveal avascular zone (FAZ) area, or vessel density."
  },
  {
    "doc_id": "PMID_41617091",
    "summary": "We used a retrospective cohort study design to test the hypothesis that greater meal fat storage in subcutaneous adipose tissue would be associated with greater future weight gain. Body composition, demographic, and meal fatty acid metabolism data was collated from 154 non-obese research volunteers who participated in studies conducted at Mayo Clinic between 1997 and 2012 that used either The long-term (19 \u00b1 7) years weight change for females was correlated with meal fat storage (P = 0.003, r=0.38) and meal fat oxidation measured using The finding that weight change is correlated with dietary fatty acid metabolism for adult, non-obese females suggests that inter-individual variations in how women process dietary fat can influence long-term energy balance. https://clinicaltrials.gov/study/NCT00254371?term=testosterone&cond=%22Sarcopenia%22&viewType=Table&rank=9."
  },
  {
    "doc_id": "PMID_41623136",
    "summary": "The REmission of diabetes using a PlAnt-based weight loss InteRvention (REPAIR) trial will assess whether a 52-week plant-based ILI targeting \u226515% weight loss is effective for diabetes remission in a multi-ethnic Canadian population. They will be randomised to standard of care or a 2-phase ILI targeting \u226515% weight loss consisting of a 12-week weight loss phase on a plant-based total diet meal replacement, followed by a 40-week weight loss maintenance phase on a plant-based dietary pattern combined with a 16-week structured exercise program, and a 52-week (19-session) sustainable behaviour change curriculum. They will be randomised to standard of care or a 2-phase ILI targeting \u226515% weight loss consisting of a 12-week weight loss phase on a plant-based total diet meal replacement, followed by a 40-week weight loss maintenance phase on a plant-based dietary pattern combined with a 16-week structured exercise program, and a 52-week (19-session) sustainable behaviour change curriculum."
  },
  {
    "doc_id": "PMID_41639820",
    "summary": "Both biomarkers predicted poor prognosis: APN (Area Under the Curve (AUC) = 0.765), sICAM-1 (AUC = 0.841). Both biomarkers predicted poor prognosis: APN (Area Under the Curve (AUC) = 0.765), sICAM-1 (AUC = 0.841). Serum APN and sICAM-1 levels are associated with DFU severity and prognosis, supporting their potential as predictive biomarkers in clinical practice."
  },
  {
    "doc_id": "PMID_41649911",
    "summary": "VAS scores in the experimental group were significantly higher before (p=0.003) and lower during (p<0.001) the procedure compared with the control group. VAS scores in the experimental group were significantly higher before (p=0.003) and lower during (p<0.001) the procedure compared with the control group. In this trial, applying cold 0.9% NaCl during sharp debridement reduced pain in patients with diabetic foot."
  },
  {
    "doc_id": "PMID_41649457",
    "summary": "The primary safety endpoint was the incidence of adverse events; the primary efficacy endpoint was the incidence of posterior capsule opacification (PCO) postoperatively at 12 months. The primary safety endpoint was the incidence of adverse events; the primary efficacy endpoint was the incidence of posterior capsule opacification (PCO) postoperatively at 12 months. A control group was formed retrospectively for comparison of PCO at 12 months."
  },
  {
    "doc_id": "PMID_41574641",
    "summary": "All 13 PG-CAP patients showed improvement (100%), compared to only 69% of the 13 MediHoney patients (p = 0.023). All 13 PG-CAP patients showed improvement (100%), compared to only 69% of the 13 MediHoney patients (p = 0.023). Our findings support PG-CAP as safe, noninferior and possibly more effective than MediHoney in healing chronic contaminated wounds."
  },
  {
    "doc_id": "PMID_41553109",
    "summary": "Of 113 patients, 79 (69.9%, mean age 50 (s.d. 8.7) years, 50 (63%) females) patients were available for 10-year follow-up (41 standard RYGB, 38 distal RYGB). Four patients underwent revisional surgery due to malnutrition after distal RYGB. Four patients underwent revisional surgery due to malnutrition after distal RYGB."
  },
  {
    "doc_id": "PMID_41640096",
    "summary": "This multicenter, transdisciplinary Consortium developed the concept of bladder health and studied it systematically in RISE FOR HEALTH (RISE). The resources developed and the data generated will be made available for use through the NIDDK repository, providing the content for many more accomplishments in the field of bladder health. Clinical Trial Registration: NCT05365971."
  },
  {
    "doc_id": "PMID_41559729",
    "summary": "This mediation proportion was significantly higher among women who were overweight at baseline, accounting for 24.3-34.7% of the intervention's benefit. This mediation proportion was significantly higher among women who were overweight at baseline, accounting for 24.3-34.7% of the intervention's benefit. Weight loss is a quantifiable and clinically relevant, though partial, mechanism by which lifestyle intervention reduces postpartum diabetes risk, particularly in overweight women with a history of GDM."
  },
  {
    "doc_id": "PMID_41636548",
    "summary": "Glucagon-like peptide-1 receptor agonists and glucose-dependent insulinotropic polypeptide coagonists have revolutionized the treatment of type 2 diabetes and obesity. This review examines the pathophysiological mechanisms underlying muscle loss with incretin-based therapies, analyzes clinical trial data on body composition changes, explores the bidirectional relationship between sarcopenia and cardiovascular disease, and evaluates emerging pharmacological and lifestyle interventions to preserve muscle mass. Understanding and mitigating muscle loss is critical for optimizing cardiovascular outcomes, particularly in older adults and those with established heart disease, where sarcopenia is associated with increased mortality and functional decline."
  },
  {
    "doc_id": "PMID_41631344",
    "summary": "Nearly half of the people taking semaglutide still had food in their stomach before surgery. Nearly half of the people taking semaglutide still had food in their stomach before surgery. Only about 1 in 5 people not taking semaglutide had food in their stomach."
  },
  {
    "doc_id": "PMID_41622389",
    "summary": "Calsequestrin 2 (CASQ2) has emerged as a central sensor and modulator of calcium (Ca"
  },
  {
    "doc_id": "PMID_41615170",
    "summary": "To evaluate the interaction between contrast volume and contrast type (iso-osmolar vs low-osmolar) in the development of CIN. Mean contrast volume was 75.3 \u00b1 28.0 mL in Group I and 188.6 \u00b1 46.9 mL in Group II. A amostra total (n = 2.268) foi estratificada por volume: Grupo I (< 150 ml; n = 1.985) e Grupo II (\u2265 150 ml; n = 283), e comparada segundo o tipo de contraste."
  },
  {
    "doc_id": "PMID_41609947",
    "summary": "When comparing HD-IV with SD-IV, hazard ratios of hospitalizations for pneumonia and influenza were similar across CCI groups (HR [95%CI]: 0.15 When comparing HD-IV with SD-IV, hazard ratios of hospitalizations for pneumonia and influenza were similar across CCI groups (HR [95%CI]: 0.15 [0.24-1.36] for CCI \u2265 3)."
  },
  {
    "doc_id": "PMID_41649918",
    "summary": "Populations presenting with wounds (such as trauma and ulcers) are typically heterogeneous, and often exhibit a range of comorbidities and secondary factors that influence both the nature of the lesion itself and the trajectory of wound healing. The author has been a chief medical officer and independent consultant to the wound care industry for >35 years, and some statements in this article are based on his personal experience and observations. The author has been a chief medical officer and independent consultant to the wound care industry for >35 years, and some statements in this article are based on his personal experience and observations."
  },
  {
    "doc_id": "PMID_41635446",
    "summary": "The model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, and F1 score. The model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, and F1 score. Features like 'TBR', '%CV', 'GMI,' and 'GRI' were key features, suggesting their usefulness in identifying individuals at risk for adverse glycemic events."
  },
  {
    "doc_id": "PMID_41543854",
    "summary": "[95% CI, -0.140 to -0.004] mg/dL) vs placebo, but not other secondary outcomes. [95% CI, -6.33 to -0.51] mg/dL) and high-sensitivity C-reactive protein (hs-CRP) (-0.072 [95% CI, -0.140 to -0.004] mg/dL) vs placebo, but not other secondary outcomes."
  }
]